Clinical Trial

A Pilot Study on Efficacy of Digital Therapeutic NDTx-02 for Executive Function in Children and Adolescents With ADHD or ASD

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 21, 2025 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to explore the preliminary safety and effectiveness of the digital therapeutic device 'NDTx-02' in supporting improvements of executive function in children and adolescents diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD) or Autism Spectrum Disorder (ASD).
Trial Details
NCT Number NCT07242625
Lead Sponsor Neudive Inc.
Conditions Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorder
Enrollment 48 participants
Start Date 2025-10-16
Primary Completion 2026-04 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2025-11-21